165 related articles for article (PubMed ID: 37803446)
1. Clinical significance and immune infiltration analyses of a novel coagulation-related signature in ovarian cancer.
Yang J; Wang C; Zhang Y; Cheng S; Wu M; Gu S; Xu S; Wu Y; Sheng J; Voon DC; Wang Y
Cancer Cell Int; 2023 Oct; 23(1):232. PubMed ID: 37803446
[TBL] [Abstract][Full Text] [Related]
2. A novel autophagy-related gene signature associated with prognosis and immune microenvironment in ovarian cancer.
Yang J; Wang C; Zhang Y; Cheng S; Wu M; Gu S; Xu S; Wu Y; Wang Y
J Ovarian Res; 2023 Apr; 16(1):86. PubMed ID: 37120633
[TBL] [Abstract][Full Text] [Related]
3. A Novel pyroptosis-related signature for predicting prognosis and evaluating tumor immune microenvironment in ovarian cancer.
Yang J; Wang C; Zhang Y; Cheng S; Xu Y; Wang Y
J Ovarian Res; 2023 Sep; 16(1):196. PubMed ID: 37730669
[TBL] [Abstract][Full Text] [Related]
4. Construction and validation of a novel ferroptosis-related signature for evaluating prognosis and immune microenvironment in ovarian cancer.
Yang J; Wang C; Cheng S; Zhang Y; Jin Y; Zhang N; Wang Y
Front Genet; 2022; 13():1094474. PubMed ID: 36685851
[TBL] [Abstract][Full Text] [Related]
5. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
6. Integrative transcriptional characterization of cell cycle checkpoint genes promotes clinical management and precision medicine in bladder carcinoma.
Shi WW; Guan JZ; Long YP; Song Q; Xiong Q; Qin BY; Ma ZQ; Hu Y; Yang B
Front Oncol; 2022; 12():915662. PubMed ID: 36033441
[TBL] [Abstract][Full Text] [Related]
7. Assessing of programmed cell death gene signature for predicting ovarian cancer prognosis and treatment response.
Lian X; Liu B; Wang C; Wang S; Zhuang Y; Li X
Front Endocrinol (Lausanne); 2023; 14():1182776. PubMed ID: 37342266
[TBL] [Abstract][Full Text] [Related]
8. A Novel Platinum Resistance-Related Immune Gene Signature for Overall Survival Prediction in Patients with Ovarian Cancer.
Zhou C; Ma J; Luo W; Hu J; Chen J; Liang S; He S
Biochem Genet; 2024 Feb; 62(1):112-124. PubMed ID: 37270714
[TBL] [Abstract][Full Text] [Related]
9. A novel extrachromosomal circular DNA related genes signature for overall survival prediction in patients with ovarian cancer.
Zhang Y; Dong K; Jia X; Du S; Wang D; Wang L; Qu H; Zhu S; Wang Y; Wang Z; Zhang S; Sun W; Fu S
BMC Med Genomics; 2023 Jun; 16(1):140. PubMed ID: 37337170
[TBL] [Abstract][Full Text] [Related]
10. Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq.
Zhang D; Lu W; Cui S; Mei H; Wu X; Zhuo Z
J Ovarian Res; 2022 Nov; 15(1):123. PubMed ID: 36424614
[TBL] [Abstract][Full Text] [Related]
11. A prognosis-predictive nomogram of ovarian cancer with two immune-related genes:
Lin H; Wang J; Wen X; Wen Q; Huang S; Mai Z; Lu L; Liang X; Pan H; Li S; He Y; Ma H
Oncol Lett; 2020 Nov; 20(5):204. PubMed ID: 32963610
[TBL] [Abstract][Full Text] [Related]
12. A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma.
Yang T; Luo Y; Liu J; Liu F; Ma Z; Liu G; Li H; Wen J; Chen C; Zeng X
Front Oncol; 2023; 13():1182434. PubMed ID: 37346073
[TBL] [Abstract][Full Text] [Related]
13. The m6A-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Tumor Immune Infiltration in Ovarian Cancer.
Geng R; Chen T; Zhong Z; Ni S; Bai J; Liu J
Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36011053
[No Abstract] [Full Text] [Related]
14. Systemic characterization of alternative splicing related to prognosis, immune infiltration, and drug sensitivity analysis in ovarian cancer.
Liu Q; Zhang H; Yang X; Liu X; Yin F; Guo P; Yin Y; Zheng K; Yang Z; Han Y
Ann Transl Med; 2022 Jan; 10(2):126. PubMed ID: 35282039
[TBL] [Abstract][Full Text] [Related]
15. Novel gene signatures for prognosis prediction in ovarian cancer.
Bao M; Zhang L; Hu Y
J Cell Mol Med; 2020 Sep; 24(17):9972-9984. PubMed ID: 32666642
[TBL] [Abstract][Full Text] [Related]
16. Construction of Ovarian Cancer Prognostic Model Based on the Investigation of Ferroptosis-Related lncRNA.
Yang S; Ji J; Wang M; Nie J; Wang S
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830675
[TBL] [Abstract][Full Text] [Related]
17. Characterization of coagulation-related gene signature to predict prognosis and tumor immune microenvironment in skin cutaneous melanoma.
Song B; Chi H; Peng G; Song Y; Cui Z; Zhu Y; Chen G; Wu J; Liu W; Dong C; Wang Y; Xu K; Yu Z; Song B
Front Oncol; 2022; 12():975255. PubMed ID: 36059641
[TBL] [Abstract][Full Text] [Related]
18. A clinical prognostic model of oxidative stress-related genes linked to tumor immune cell infiltration and the prognosis of ovarian cancer patients.
Li L; Zhang W; Sun Y; Zhang W; Lu M; Wang J; Jin Y; Xi Q
Heliyon; 2024 Apr; 10(7):e28442. PubMed ID: 38560253
[TBL] [Abstract][Full Text] [Related]
19. Identification of a Prognostic Signature for Ovarian Cancer Based on Ubiquitin-Related Genes Suggesting a Potential Role for FBXO9.
Luo X; Wang Y; Zhang H; Chen G; Sheng J; Tian X; Xue R; Wang Y
Biomolecules; 2023 Nov; 13(12):. PubMed ID: 38136595
[TBL] [Abstract][Full Text] [Related]
20. Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma.
Yao J; Duan L; Huang X; Liu J; Fan X; Xiao Z; Yan R; Liu H; An G; Hu B; Ge Y
Front Oncol; 2021; 11():769727. PubMed ID: 34926275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
